An Open-Label, Single-Dose Study to Assess the Pharmacokinetics of the Hydrocodone Bitartrate Extended-Release Tablet (45 mg) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal Impairment.
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2016
At a glance
- Drugs Hydrocodone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Cephalon
- 01 Mar 2016 Results published in the Clinical Pharmacology in Drug Development.
- 31 Dec 2011 Actual initiation date changed from Jan 2011 to Mar 2011 and actual patients number (55) added as reported by ClinicalTrials.gov.
- 31 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.